Edition:
United Kingdom

Arrowhead Pharmaceuticals Presents Preclinical Data On Expanding Cardiometabolic Pipeline


Friday, 11 May 2018 

May 11 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS PRESENTS PRECLINICAL DATA ON EXPANDING CARDIOMETABOLIC PIPELINE.ARROWHEAD PHARMACEUTICALS - INTENDS TO FILE CLINICAL TRIAL APPLICATIONS FOR ARO-ANG3 & ARO-APOC3 BEFORE END OF 2018. 

Company Quote

27.8
0.65 +2.39%
15 Jul 2019